Patents-Review.com
ClassID:

20671 ⎘

A61K35/76 - page 3 - CPC Classification

Classification description:

Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Microorganisms or materials therefrom Viruses; Subviral particles; Bacteriophages

Recent Application in this class:
#601
20200155624
2020-05-21

Compositions and methods of treating Huntington's disease

 #602
20200149066
2020-05-14

Method for Introducing Polynucleotide to Male Germ Cell or Sertoli Cell

 #603
20200149019
2020-05-14

Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS) produced by human neural or glial cells

 #604
20200147240
2020-05-14

TREATMENT OF COMPLEMENT-MEDIATED DISORDERS

 #605
20200147185
2020-05-14

AAV9-mediated gene therapy for treating mucopolysaccharidosis type I

 #606
20200147120
2020-05-14

FUNCTION INHIBITOR OF SWI/SNF COMPLEXES

 #607
20200131539
2020-04-30

CRISPR/Cas 9-mediated integration of polynucleotides by sequential homologous recombination of AAV donor vectors

 #608
20200131531
2020-04-30

Borna viral vector and use thereof

 #609
20200129628
2020-04-30

Methods and compositions relating to carnitine-derived materials

 #610
20200121780
2020-04-23

METHODS TO REDUCE THE LIKELIHOOD OF MATERNAL AND FETAL ZIKA VIRUS DISEASE

 #611
20200121745
2020-04-23

COMPOSITIONS AND METHODS FOR CANCER THERAPY WITH DENGUE VIRUS AND DENDRITIC CELLS

 #612
20200121744
2020-04-23

COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES AND MAINTAINING HEALTHY SKIN

 #613
20200113981
2020-04-16

CNS delivery of therapeutic agents

 #614
20200109180
2020-04-09

Anti-tumor properties of Dickkopf 3b

 #615
20200108108
2020-04-09

TOBACCO MOSAIC VIRUS DELIVERY OF MITOXANTRONE FOR CANCER THERAPY

 #616
20200102545
2020-04-02

DELIVERY OF PACKAGED RNA TO MAMMALIAN CELLS

 #617
20200087682
2020-03-19

Compositions and methods for treating phenylketonuria

 #618
20200078425
2020-03-12

Methods and Compositions for Treating Obesity, Inflammation, or Metabolic Disorders with Bacteriophages

 #619
20200078424
2020-03-12

COMPOSITIONS AND METHODS FOR THERAPY WITH DENGUE VIRUS

 #620
20200069752
2020-03-05

Cancer immunotherapy using virus particles

 #621
20200069751
2020-03-05

Dengue vaccine unit dose and administration thereof

 #622
20200069574
2020-03-05

Therapeutic methods involving gastrointestinal implants for administering metabolic agents

 #623
20200061182
2020-02-27

Influenza virus mutants and uses therefor

 #624
20200057081
2020-02-20

System and Method for Managing Animal Cancers by Disabling the Cancer Cells Ability to Reproduce

 #625
20200056203
2020-02-20

Treating Animal Cancers Through Programmed Cancer Cell Death

 #626
20200054700
2020-02-20

bacteriophage Ent-FAP-4 and use for inhibiting proliferation of same

 #627
20200054699
2020-02-20

Pharmaceutical composition based on bacteriophages against ; use in the treatment of diseases associated with this pathogen

 #628
20200054042
2020-02-20

bacteriophage Clo-PEP-2 and use for inhibiting proliferation of same

 #629
20200046810
2020-02-13

Methods and compositions for CNS delivery of iduronate-2-sulfatase

 #630
20200040346
2020-02-06

Optimized vector for delivery in microbial populations

 #631
20200038462
2020-02-06

METHODS AND COMPOSITIONS OF OTC CONSTRUCTS AND VECTORS

 #632
20200030392
2020-01-30

Anti-bacterial compositions and uses thereof

 #633
20200030391
2020-01-30

VIRUS AAV/IGF2, GENETIC TREATMENT METHOD AND USE THEREOF IN PROTEIN MISFOLDING-RELATED DISEASES, SUCH AS HUNTINGTON'S DISEASE

 #634
20200009245
2020-01-09

Vector-based attenuated poxvirus vaccines

 #635
20190388487
2019-12-26

Detargeted adenovirus variants and related methods

 #636
20190382452
2019-12-19

Modified capsid proteins for enhanced delivery of parvovirus vectors

 #637
20190367886
2019-12-05

METHOD FOR PRODUCING VACCINIA VIRUS EXPRESSING FOREIGN GENE

 #638
20190365925
2019-12-05

AAV vectors targeted to the central nervous system

 #639
20190365834
2019-12-05

Bacteriophage Compositions And Methods Of Selection Of Components Against Specific Bacteria

 #640
20190359949
2019-11-28

bacteriophage pse-AEP-4 and use thereof for inhibiting proliferation of

#641
20190359948
2019-11-28

bacteriophage Pse-AEP-3 and use thereof for inhibiting proliferation of

#642
20190359947
2019-11-28

THERAPEUTIC BACTERIOPHAGE COMPOSITIONS

 #643
20190359694
2019-11-28

Serological assay for the detection of zika virus-specific antibodies utilizing overlapping peptides comprising an NS2B epitope

 #644
20190358306
2019-11-28

AADC polynucleotides for the treatment of Parkinson's disease

 #645
20190358276
2019-11-28

NOVEL THERAPEUTIC AGENT FOR PRIONOID DISEASES

 #646
20190350991
2019-11-21

TREATMENT OF TOPICAL AND SYSTEMIC BACTERIAL INFECTIONS

 #647
20190350990
2019-11-21

Virus-like particle of Senecavirus A

 #648
20190336549
2019-11-07

Therapeutic agents and uses thereof for drugs for treatment of tumors and/or cancers

 #649
20190328804
2019-10-31

AAV vectors targeted to oligodendrocytes

 #650
20190328803
2019-10-31

bacteriophage Vib-PAP-4 and use thereof in inhibiting proliferation of bacteria

 #651
20190322755
2019-10-24

CAR expression vector and CAR-expressing T cells

 #652
20190321424
2019-10-24

bacteriophage Esc-COP-7, and use thereof for suppressing proliferation of pathogenic

#653
20190321423
2019-10-24

bacteriophage Esc-COP-9 and use for inhibiting proliferation of pathogenic thereof

 #654
20190321422
2019-10-24

Bacteriophage variants having extended host-range, methods for preparation and uses thereof in transducing nucleic acids into hosts of interest

 #655
20190321421
2019-10-24

Fecal virome and therapeutic efficacy of fecal microbiota transplantation

 #656
20190316183
2019-10-17

FAST DIAGNOSIS AND PERSONALIZED TREATMENTS FOR ACNE

 #657
20190316153
2019-10-17

Packaging cell for making a pseudotyped lentivirus

 #658
20190316151
2019-10-17

ENGINEERED VIRAL VECTOR REDUCES INDUCTION OF INFLAMMATORY AND IMMUNE RESPONSES

 #659
20190307819
2019-10-10

STABILISATION OF VIRAL PARTICLES

 #660
20190307818
2019-10-10

NOVEL ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE

 #661
20190300902
2019-10-03

Stable pseudotyped lentiviral particles and uses thereof

 #662
20190298805
2019-10-03

Glucagon analogs and methods of use thereof

 #663
20190298785
2019-10-03

AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity

 #664
20190298764
2019-10-03

Combination immunotherapies for treatment of cancer

 #665
20190290782
2019-09-26

Papillomavirus pseudoviruses for detection and therapy of tumors

 #666
20190290750
2019-09-26

DNA ANTIBODY CONSTRUCTS FOR USE AGAINST EBOLA VIRUS

 #667
20190290709
2019-09-26

Bacteriophage compositions comprising respiratory antibacterial phages and methods of use thereof

 #668
20190290704
2019-09-26

Probiotic recolonisation therapy

 #669
20190290674
2019-09-26

Composition for promoting production of immunostimulatory factor

 #670
20190284540
2019-09-19

Butyrylcholinesterases having an enhanced ability to hydrolyze acyl ghrelin

 #671
20190282639
2019-09-19

Viral vectors for treating Parkinson's disease

 #672
20190275091
2019-09-12

Anticancer agent comprising HVJ-E and immune checkpoint protein inhibitor

 #673
20190271006
2019-09-05

Method for producing transgenic cell

 #674
20190269729
2019-09-05

Modified natural killer cells for the treatment of cancer

 #675
20190264226
2019-08-29

Non-integrating viral delivery system and methods related thereto

 #676
20190262309
2019-08-29

Enhanced Gene Delivery to Natural Killer Cells, Hematopoietic Stem Cells and Macrophages

 #677
20190255126
2019-08-22

Adeno-associated virus formulations

 #678
20190255125
2019-08-22

Vaccine compositions comprising an attenuated mutant Zika virus

 #679
20190249149
2019-08-15

Compositions and methods for treating acne

 #680
20190247479
2019-08-15

Compositions and methods for combination therapy with dengue virus and dendritic cells

 #681
20190247451
2019-08-15

Microencapsulation of bacteriophages and related products

 #682
20190231832
2019-08-01

Compositions and methods for enhancing growth, spread, and oncolytic and immunotherapeutic efficacy of oncolytic RNA viruses

 #683
20190231831
2019-08-01

bacteriophage Bor-BRP-1, and use thereof for inhibition of proliferation of bacteria

 #684
20190225969
2019-07-25

CTLA-4-targeting trans-splicing ribozyme for delivery of chimeric antigen receptor, and use thereof

 #685
20190224258
2019-07-25

Bacteriophage and composition comprising same

 #686
20190224257
2019-07-25

Drug composition for angiogenesis therapy

 #687
20190224256
2019-07-25

GENERATION OF NEURONS BY REPROGRAMMING OF OLIGODENDROCYTES AND OLIGODENDROCYTE PRECURSOR CELLS

 #688
20190218590
2019-07-18

Methods and systems for the rapid detection of cronobacter using infectious agents

 #689
20190218589
2019-07-18

Methods and systems for the rapid detection of using infectious agents

 #690
20190218522
2019-07-18

Chimeric poxvirus compositions and uses thereof

 #691
20190216898
2019-07-18

Interleukin Combination and Use Thereof

 #692
20190209712
2019-07-11

HUMANIZED MURINE MODEL OF CHRONIC HEPATITIS B CONSTRUCTED USING STEM CELLS AND METHOD OF USING SAME

 #693
20190209709
2019-07-11

SYSTEM AND METHOD TO MODULATE PAIN AND ITCH THROUGH CUTANEOUS TRANSFER OF GENETIC INFORMATION

 #694
20190194294
2019-06-27

Agent for restoring visual function or agent for preventing deterioration in visual function

 #695
20190194292
2019-06-27

Enveloped virus resistant to complement inactivation for the treatment of cancer

 #696
20190192592
2019-06-27

Live attenuated recombinant HMPV with mutations in PDZ motifs of M2-2 protein, vaccine containing and use thereof

 #697
20190192583
2019-06-27

Drugs (variants) and methods for restoring microflora

 #698
20190183984
2019-06-20

Methods and compositions for CNS delivery of heparan n-sulfatase

 #699
20190183945
2019-06-20

bacteriophage VIB-ANP-1 and use thereof for inhibiting proliferation of bacteria

 #700
20190177731
2019-06-13

Engineered viral vector reduces induction of inflammatory and immune responses

 #701
20190175671
2019-06-13

MICRORNA 22 REGULATORS COMPOSITIONS AND METHODS AND USES THEREOF

 #702
20190169578
2019-06-06

Methods and compositions for production of vaccina virus

 #703
20190167736
2019-06-06

BACTERIOPHAGE FOR TREATING STAPHYLOCOCCUS INFECTIONS

 #704
20190167718
2019-06-06

Compositions and methods for activating antigen presenting cells with chimeric poliovirus

 #705
20190160121
2019-05-30

bacteriophage Vib-PAP-5 and use thereof for suppressing proliferation of bacteria

 #706
20190160120
2019-05-30

DNA, METHODS ETC

 #707
20190153399
2019-05-23

Bacteriophage and composition comprising same

 #708
20190151436
2019-05-23

Method of enhancing innate immune responses against a tumor comprising administering lymphocytic choriomeningitis virus (LCMV)

 #709
20190151253
2019-05-23

Nanoscale coatings for encapsulation of biological entities

 #710
20190142935
2019-05-16

Formulation containing TLR agonist and methods of use

 #711
20190142882
2019-05-16

Microbial production of pure single stranded nucleic acids

 #712
20190142881
2019-05-16

BACTERIOPHAGE COMPOSITIONS AND USES THEREOF

 #713
20190136246
2019-05-09

Plant-produced chimaeric Orbivirus VLPs

 #714
20190134228
2019-05-09

System and Method for Managing All Cancers by Disabling the Cancer Cells Ability to Reproduce

 #715
20190127708
2019-05-02

MESSENGER RNA BASED VIRAL PRODUCTION

 #716
20190119652
2019-04-25

Bacteriophage strain capable of producing a lytic infection in the ST131-025B:H4 clone

 #717
20190119651
2019-04-25

Anti-bacterial compositions comparing lytic modified bacteriophage engineered to infect and kill different target bacteria

 #718
20190117710
2019-04-25

METHODS FOR REGULATING ENDOGENOUS PRODUCTION OF CHECKPOINT PROTEINS

 #719
20190111116
2019-04-18

Compositions and methods for treating MPSI

 #720
20190111092
2019-04-18

Therapeutic viral microparticles for promoting stent biofunctionality and wound healing in vertebrate individuals

 #721
20190099460
2019-04-04

Method for treating cancer with a Coxsackievirus B3 (CVB3) variant

 #722
20190099459
2019-04-04

Methods and compositions for preventing infection by a species

 #723
20190093100
2019-03-28

Modifying bacteriophage

 #724
20190091315
2019-03-28

Immunity-inducing agent

 #725
20190083610
2019-03-21

Bacteriophage-polymer hybrid

 #726
20190083553
2019-03-21

Modified arenavirus

 #727
20190083552
2019-03-21

Immunogenic composition

 #728
20190076505
2019-03-14

Immunogenic peptides of SCD1 protein

 #729
20190076492
2019-03-14

Immunity-inducing agent

 #730
20190071671
2019-03-07

Therapeutic for treatment of diseases including the central nervous system

 #731
20190070232
2019-03-07

METHODS OF CLONING PROPHAGES AND PRODUCING LYTIC PHAGE PARTICLES

 #732
20190070231
2019-03-07

Composition comprising bacteriophages for reducing, eliminating and/or preventing , and B

 #733
20190062784
2019-02-28

Replication-defective arenavirus vectors

 #734
20190062395
2019-02-28

IL-2 superagonists in combination with anti-PD-1 antibodies

 #735
20190060441
2019-02-28

Influenza virus mutants and uses therefor

 #736
20190060380
2019-02-28

Methods of identifying bacteriophages that can infect and kill host-adapted infectious pathogenic bacteria

 #737
20190060239
2019-02-28

Technology for the Preparation of Microparticles

 #738
20190054131
2019-02-21

Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy

 #739
20190054129
2019-02-21

REDUCING CONJUGATIVE PLASMIDS IN BACTERIA

 #740
20190048363
2019-02-14

AAV-IDUA vector for treatment of MPS I-associated blindness

 #741
20190048082
2019-02-14

Oncolytic viral delivery of therapeutic polypeptides

 #742
20190046622
2019-02-14

Compositions and methods for combination therapy with dengue virus and dendritic cells

 #743
20190038677
2019-02-07

PREVENTIVE OR THERAPEUTIC AGENT FOR MUSCLE INJURY

 #744
20190032022
2019-01-31

Bacteriophage strains against proteus mirabilis and use thereof

 #745
20190022156
2019-01-24

Inhibitors of PI3K p-delta 110 for use in delivery of viruses in the treatment of cancer

 #746
20190022155
2019-01-24

Homogeneous engineered phage populations

 #747
20190008933
2019-01-10

AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE

 #748
20190008932
2019-01-10

AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE

 #749
20190008931
2019-01-10

AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE

 #750
20190002840
2019-01-03

Phage therapy of infections

 #751
20190000897
2019-01-03

Vibrio parahaemolyticus bacteriophage Vib-PAP-2 and use thereof for inhibiting proliferation of

#752
20190000896
2019-01-03

Delivery vehicle

 #753
20180369426
2018-12-27

COMPOSITIONS COMPRISING FLUORESCENT DYES ASSOCIATED WITH VIRAL COMPONENTS FOR NERVE IMAGING

 #754
20180369300
2018-12-27

bacteriophage Pas-MUP-1 and use thereof for inhibiting proliferation of

#755
20180369299
2018-12-27

Vibrio parahaemolyticus bacteriophage Vib-PAP-1 and use thereof for inhibiting proliferation of vibrio parahaemolyticus

 #756
20180362990
2018-12-20

THERAPEUTIC

 #757
20180362592
2018-12-20

AAV's and uses thereof

 #758
20180360935
2018-12-20

Compositions and methods related to xCT peptides

 #759
20180355378
2018-12-13

Engineered phagemids

 #760
20180344782
2018-12-06

Probiotic recolonisation therapy

 #761
20180339044
2018-11-29

PD-1 and CTLA-4 dual inhibitor peptides

 #762
20180339026
2018-11-29

Viral vectors encoding recombinant fix with increased expression for gene therapy of hemophilia B

 #763
20180334674
2018-11-22

Antitumor drug delivery formulation

 #764
20180334487
2018-11-22

Compositions for use in recovering or ameliorating deterioration of physiological functions due to aging

 #765
20180333444
2018-11-22

Bacteriophage compositions and methods of use thereof

 #766
20180326048
2018-11-15

Smallpox vaccine for cancer treatment

 #767
20180325968
2018-11-15

Skin microbiome colonizer formulations and methods for use

 #768
20180325967
2018-11-15

Stable dry compositions having no or little sugars

 #769
20180325918
2018-11-15

Immunoregulatory agent

 #770
20180313843
2018-11-01

SAMHD1 MODULATION FOR TREATING RESISTANCE TO CANCER THERAPY

 #771
20180311374
2018-11-01

TARGETED CANCER THERAPY

 #772
20180303885
2018-10-25

bacteriophage Str-INP-1 and use of the same for inhibiting the proliferation of

#773
20180289757
2018-10-11

MUTANT ADENO-ASSOCIATED VIRUS VIRIONS AND METHODS OF USE THEREOF

 #774
20180289756
2018-10-11

THERAPEUTIC BACTERIOPHAGE COMPOSITIONS

 #775
20180282703
2018-10-04

Bacteriophage and antibacterial composition comprising the same

 #776
20180273911
2018-09-27

Attenuated virus mutated at sites of evolutionarily conserved RNA structure

 #777
20180273910
2018-09-27

Antibacterial and protective bacteriophage formulations and methods for making and using them

 #778
20180273909
2018-09-27

PURIFICATION OF RESPIRATORY SYNCYTIAL VIRUS

 #779
20180258447
2018-09-13

Hairpin MRNA elements and methods for the regulation of protein translation

 #780
20180250422
2018-09-06

METHODS OF TREATING NEURODEGENERATIVE DISORDERS

 #781
20180245052
2018-08-30

Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases

 #782
20180243355
2018-08-30

Anti-cancer agent comprising HVJ-E and CXCL2

 #783
20180237753
2018-08-23

Compositions and methods for enhancing virus replication

 #784
20180228927
2018-08-16

Apparatus for virus inactivation and sampling

 #785
20180223312
2018-08-09

Capsid-modified, RAAV3 vector compositions and uses in gene therapy of human liver cancer

 #786
20180221438
2018-08-09

MODULATING URACIL-DNA GLYCOSYLASE AND USES THEREOF

 #787
20180214538
2018-08-02

Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus

 #788
20180208904
2018-07-26

Host regulatory factor that enhances replication and/or propagation of vaccinia virus

 #789
20180207211
2018-07-26

Respiratory syncytial virus with a genomic deficiency complemented in trans

 #790
20180200356
2018-07-19

Immune inducer

 #791
20180195050
2018-07-12

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

 #792
20180185516
2018-07-05

DELIVERY OF TARGET SPECIFIC NUCLEASES

 #793
20180185469
2018-07-05

Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome

 #794
20180179555
2018-06-28

Methods of delivering a pseudotyped lentivirus

 #795
20180177831
2018-06-28

Compositions for the Restoration of a Fecal Microbiota and Methods for Making and Using Them

 #796
20180177218
2018-06-28

Edible web comprising microorganisms

 #797
20180163208
2018-06-14

Method for treatment of subjects with TUG1 gene expressing brain tumor

 #798
20180161382
2018-06-14

PREBIOTIC COMPOSITIONS COMPRISING ONE OR MORE TYPES OF BACTERIOPHAGE

 #799
20180147300
2018-05-31

Glucocerebrosidase gene therapy for Parkinson's disease

 #800
20180140626
2018-05-24

RETINOL-BINDING PROTEIN 3 (RBP3) AS A PROTECTIVE FACTOR IN NON-DIABETIC RETINAL DEGENERATION

 #801
20180135074
2018-05-17

RECOMBINANT AAV VECTORS FOR GENE THERAPY OF HUMAN HEMATOPOIETIC DISORDERS

 #802
20180126006
2018-05-10

Nucleic acid molecules containing spacers outside ITR

 #803
20180117137
2018-05-03

Arenaviruses for use in the treatment and/or prevention of tumors and method for producing arenaviruses with (improved) tumor-regression properties.

 #804
20180110812
2018-04-26

Treatment of bacterial infections in aquaculture

 #805
20180110810
2018-04-26

FREEZE DRIED FECAL MICROBIOTA FOR USE IN FECAL MICROBIAL TRANSPLANTATION

 #806
20180105801
2018-04-19

Disease control of the plant bacterial pathogens causing citrus canker and rice blight

 #807
20180099015
2018-04-12

Detargeted adenovirus variants and related methods

 #808
20180092386
2018-04-05

O157:H7 bacteriophage Φ241

 #809
20180085438
2018-03-29

Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety

 #810
20180085411
2018-03-29

Optimized oncolytic viruses and uses thereof

 #811
20180078508
2018-03-22

Oncolytic virus formulation and preparation method thereof

 #812
20180071212
2018-03-15

Methods and compositions for CNS delivery of arylsulfatase A

 #813
20180066280
2018-03-08

Retroviral and lentiviral vectors

 #814
20180055997
2018-03-01

COMPARTMENTALIZED METHOD OF NUCLEIC ACID DELIVERY AND COMPOSITIONS AND USES THEREOF

 #815
20180055895
2018-03-01

BACTERIOPHAGE-CONTAINING THERAPEUTIC AGENTS

 #816
20180051300
2018-02-22

SELF-COMPLEMENTARY PARVOVIRAL VECTORS, AND METHODS FOR MAKING AND USING THE SAME

 #817
20180050098
2018-02-22

Compositions and methods for combination therapy with dengue virus and dendritic cells

 #818
20180036428
2018-02-08

Capsid modified rAAV vectors and methods of use

 #819
20180028449
2018-02-01

Technology for the Preparation of Microparticles

 #820
20180008653
2018-01-11

A METHOD OF PREVENTING INFECTION OF HYMENOPTEROUS INSECTS OF THE SUPERFAMILY APOIDEA

 #821
20180000876
2018-01-04

Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life

 #822
20180000125
2018-01-04

Lactococcus garvieae bacteriophage Lac-GAP-1 and use thereof in suppressing proliferation of lactococcus garvieae bacteria

 #823
20170368116
2017-12-28

Bacteriophage compositions and methods of selection of components against specific bacteria

 #824
20170360960
2017-12-21

AAV vectors targeted to the central nervous system

 #825
20170348365
2017-12-07

Enteropathogenic bacteriophage Esc-CHP-2 and use thereof for inhibiting proliferation of enteropathogenic

#826
20170340686
2017-11-30

Shigatoxin-producing F18 type bacteriophage esc-COP-1 and use thereof for inhibiting proliferation of shigatoxin-producing F18 type

#827
20170340685
2017-11-30

Clostridium perfringens bacteriophage Clo-PEP-1 and use thereof for inhibiting proliferation of clostridium perfringens

 #828
20170340684
2017-11-30

Tetrafunctional bacteriophage

 #829
20170335345
2017-11-23

Pharmaceutical composition for treatment and/or prevention of hepatitis C

 #830
20170333538
2017-11-23

AADC polynucleotides for the treatment of parkinson's disease

 #831
20170333500
2017-11-23

Genetically Modified Bacteriophage (Bio-Phage)

 #832
20170333499
2017-11-23

Enteroinvasive bacteriophage Esc-COP-4 and use thereof for inhibiting proliferation of enteroinvasive

#833
20170333498
2017-11-23

Enterohemorrhagic bacteriophage Esc-CHP-1 and use thereof for inhibiting proliferation of enterohemorrhagic

#834
20170326239
2017-11-16

Artificial bacteriophage based on carbon nanostructures for supplying medicaments

 #835
20170319715
2017-11-09

SYSTEM AND METHOD TO MODULATE PAIN AND ITCH THROUGH CUTANEOUS TRANSFER OF GENETIC INFORMATION

 #836
20170319638
2017-11-09

TREATMENT OF CANCER

 #837
20170319637
2017-11-09

Phage therapy

 #838
20170313991
2017-11-02

Multiple host range bacteriophage with hybrid tail fibres

 #839
20170312322
2017-11-02

Products of manufacture comprising bacteriophages

 #840
20170306298
2017-10-26

Multiple host range bacteriophage with different tail fibres

 #841
20170304422
2017-10-26

Compositions and methods for combination therapy with dengue virus and dendritic cells

 #842
20170304379
2017-10-26

Modifying bacteriophage

 #843
20170304378
2017-10-26

MODIFYING BACTERIOPHAGE USING BETA-GALACTOSIDASE AS A SELECTABLE MARKER

 #844
20170298387
2017-10-19

Virus-based expression vectors and uses thereof

 #845
20170298324
2017-10-19

Methods and compositions for production of vaccinia virus

 #846
20170298109
2017-10-19

Tumor antigen peptide

 #847
20170296601
2017-10-19

Compositions and Methods for Treating an Immunodeficiency Virus Infection

 #848
20170291953
2017-10-12

Car expression vector and car-expressing T cells

 #849
20170283810
2017-10-05

Nucleic acid constructs for presentation of CD4 and CD8 epitopes, cellular transfection and uses thereof

 #850
20170281700
2017-10-05

PHAGE THERAPY FOR TARGETING ENTEROCOCCI

 #851
20170274024
2017-09-28

AAV Vectors Targeted to Oligodendrocytes

 #852
20170266270
2017-09-21

Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist and/or Agonist of an Immune Checkpoint Inhibitor

 #853
20170266239
2017-09-21

Compositions for the Restoration of a Fecal Microbiota and Methods for Making and Using Them

 #854
20170260546
2017-09-14

Targeted elimination of bacterial genes

 #855
20170258765
2017-09-14

Priming of pancreatic tumor cells and cancer stem cells to TRAIL-induced apoptosis

 #856
20170252413
2017-09-07

Nano-scale delivery device and uses thereof

 #857
20170246288
2017-08-31

MULTILAMELLAR LIPID VESICLE COMPOSITIONS AND METHODS OF USE

 #858
20170224738
2017-08-10

Method for protecting liver and a liver protecting agent

 #859
20170216380
2017-08-03

BENEFICIAL EFFECTS OF BACTERIOPHAGE TREATMENTS

 #860
20170202891
2017-07-20

Pegylated recombinant bacteriophage

 #861
20170189544
2017-07-06

POLYMER CONJUGATES WITH DECREASED ANTIGENICITY, METHODS OF PREPARATION AND USES THEREOF

 #862
20170189460
2017-07-06

Bacteriophage and composition comprising same

 #863
20170189459
2017-07-06

Bacteriophage and composition comprising same

 #864
20170175137
2017-06-22

Retroviral vector having immune-stimulating activity

 #865
20170173181
2017-06-22

Methods of treating neurodegenerative disorders

 #866
20170157186
2017-06-08

PHAGE TO TREAT BACTERIA ON SKIN

 #867
20170143779
2017-05-25

AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity

 #868
20170143778
2017-05-25

A METHOD OF FEEDING AN ANIMAL TO IMPROVE GROWTH EFFICIENCY

 #869
20170137786
2017-05-18

Enhanced adoptive cell therapy

 #870
20170130208
2017-05-11

Compositions and methods for purifying recombinant adeno-associated virus

 #871
20170128528
2017-05-11

Modified Friedreich ataxia genes and vectors for gene therapy

 #872
20170128504
2017-05-11

Bacteriophage and antibacterial composition comprising the same

 #873
20170119829
2017-05-04

METHOD FOR INDUCING PRODUCTION OF VASCULAR ENDOTHELIAL GROWTH FACTOR

 #874
20170086465
2017-03-30

ANTINEMATODAL METHODS AND COMPOSITIONS

 #875
20170080078
2017-03-23

Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome

 #876
20170065649
2017-03-09

Therapeutic bacteriophage compositions

 #877
20170065647
2017-03-09

COMPOSITIONS AND METHODS FOR TREATING SKIN AND MUCOUS MEMBRANE DISEASES

 #878
20170058328
2017-03-02

Fast diagnosis and personalized treatments for acne

 #879
20170051261
2017-02-23

Butyrylcholinesterases having an enhanced ability to hydrolyze acyl ghrelin

 #880
20170044504
2017-02-16

Adeno-associated virus virions with variant capsid and methods of use thereof

 #881
20170043010
2017-02-16

Smallpox vaccine for cancer treatment

 #882
20170042978
2017-02-16

CNS delivery of therapeutic agents

 #883
20170037414
2017-02-09

THERAPEUTIC

 #884
20170037382
2017-02-09

Bacteriophage and composition comprising same

 #885
20170037380
2017-02-09

Bacteriophage and composition comprising same

 #886
20170035817
2017-02-09

Bacteriophage and composition comprising same

 #887
20170035077
2017-02-09

Method of inhibiting the growth of

#888
20170028017
2017-02-02

Microcin and uses thereof

 #889
20170028002
2017-02-02

Compositions and methods for treating diseases

 #890
20170020937
2017-01-26

TREATMENT OF TOPICAL AND SYSTEMIC BACTERIAL INFECTIONS

 #891
20170000878
2017-01-05

Constrained immunogenic compositions and uses therefor

 #892
20170000868
2017-01-05

Compositions and methods for combination therapy with dengue virus and dendritic cells

 #893
20170000831
2017-01-05

Phage therapy of infections

 #894
20160375139
2016-12-29

Composition comprising a polymer and a bioactive agent and method of preparing thereof

 #895
20160375068
2016-12-29

Probiotic recolonisation therapy

 #896
20160375067
2016-12-29

Probiotic recolonisation therapy

 #897
20160375066
2016-12-29

Probiotic recolonisation therapy

 #898
20160340692
2016-11-24

Recombinant retrovirus pseudotyped with E2 alphavirus glycoprotein

 #899
20160340653
2016-11-24

Delivery of packaged RNA to mammalian cells

 #900
20160331827
2016-11-17

Recombinant rift valley fever (RVF) viruses and methods of use